FINWIRES · TerminalLIVE
FINWIRES

Buchang Pharma Unit Completes Business Scope Expansion

By

Shandong Buchang Pharmaceuticals (SHA:603858) subsidiary Buchang Qihang Pharmaceutical Sales completed the industrial and commercial registration changes to expand its business scope, according to a Wednesday filing with the Shanghai bourse.

The subsidiary, with a registered capital of 6 million yuan, now holds approval for pharmaceutical retail and wholesale, Class III medical device operations, disinfection device sales, and road freight transport.

Shares of the pharmaceutical company were down 1% Wednesday.

Related Articles

Asia

Gold Mantis Construction Decoration's Vietnamese Unit Bags Four Hotel Projects for 989 Billion Dong

Suzhou Gold Mantis Construction Decoration's (SHE:002081) unit, Gold Mantis (Vietnam) Construction, won the bid for four projects for 989.4 billion Vietnamese dong, according to a Shenzhen bourse filing on Wednesday.Olympia Limited Liability Company awarded the contract to Gold Mantis Vietnam.The four projects are the fit-out and the installation of cables at VOCO Hotel, and the interior decoration and installation of cables in Crowne Plaza.The building decoration company's shares fell 3% at the close.

$SHE:002081
Asia

CHN Energy's Power Generation Slips 5% in May

CHN Energy Changyuan Electric Power's (SHE:000966) power generation in May declined 4.6% to 2.83 billion kilowatt hours from a year earlier, according to a Wednesday filing on the Shenzhen bourse.Thermal and new energy generation, respectively, dropped 7.1% and 28.3% year on year, while hydropower soared 116.2% from a year earlier.Between January and May, the company's power generation rose 1.9% year on year to 14.5 billion kWh.The Chinese power company's shares jumped 4% at the close.

$SHE:000966
Asia

Hong Kong Stocks Retreat Amid Outflows; Beijing Shougang LanzaTech Soars in Debut

Hong Kong stocks retreated Wednesday as outflows from the city to mainland exchanges weighed on investor sentiment.The Hang Seng Index fell by around 405.11 points, or 1.6%, to end at 25,633.21, while the Hang Seng China Enterprises Index decreased by 166.38 points, or 1.9%, to close at 8,596.59.Goldman Sachs Group on Wednesday downgraded its rating on H shares to market-weight, citing the Hong Kong market's four-month underperformance against onshore peers, Bloomberg News reported.The downgrade came amid a broad sell-off from mainland investors who appeared to be investing in semiconductors and other AI-linked shares in China.Mainland-listed ETFs that invest in Hong Kong equities pulled 25 billion yuan from the city's market last week, the largest weekly outflow on record and a reversal from last year's steady inflows, according to Bloomberg data.Meanwhile, the U.S. proposed additional taxes on imports from 60 economies, including China and Hong Kong, over forced-labor trade practices, the Office of the U.S. Trade Representative said.The USTR has proposed a 10% additional tariff for economies that have partially enforced bans on the importation of certain forced labor goods, and a 12.5% tariff for all others, according to the release from the office.In corporate news, Chinese carbon capture firm Beijing Shougang LanzaTech Technology (HKG:2553) soared in its Hong Kong debut. The firm's shares closed at HK$21.06, 44% above the offer price of HK$14.60.

$^HSI$HKG:2553